These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 36711551)

  • 21. Generalizability and Out-of-Sample Predictive Ability of Associations Between Neuromelanin-Sensitive Magnetic Resonance Imaging and Psychosis in Antipsychotic-Free Individuals.
    Wengler K; Baker SC; Velikovskaya A; Fogelson A; Girgis RR; Reyes-Madrigal F; Lee S; de la Fuente-Sandoval C; Ojeil N; Horga G
    JAMA Psychiatry; 2024 Feb; 81(2):198-208. PubMed ID: 37938847
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neurocognitive and neuroanatomical maturation in the clinical high-risk states for psychosis: A pattern recognition study.
    Kambeitz-Ilankovic L; Haas SS; Meisenzahl E; Dwyer DB; Weiske J; Peters H; Möller HJ; Falkai P; Koutsouleris N
    Neuroimage Clin; 2019; 21():101624. PubMed ID: 30528960
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cortical Thickness Abnormalities at Different Stages of the Illness Course in Schizophrenia: A Systematic Review and Meta-analysis.
    Zhao Y; Zhang Q; Shah C; Li Q; Sweeney JA; Li F; Gong Q
    JAMA Psychiatry; 2022 Jun; 79(6):560-570. PubMed ID: 35476125
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heterogeneity of Psychosis Risk Within Individuals at Clinical High Risk: A Meta-analytical Stratification.
    Fusar-Poli P; Cappucciati M; Borgwardt S; Woods SW; Addington J; Nelson B; Nieman DH; Stahl DR; Rutigliano G; Riecher-Rössler A; Simon AE; Mizuno M; Lee TY; Kwon JS; Lam MM; Perez J; Keri S; Amminger P; Metzler S; Kawohl W; Rössler W; Lee J; Labad J; Ziermans T; An SK; Liu CC; Woodberry KA; Braham A; Corcoran C; McGorry P; Yung AR; McGuire PK
    JAMA Psychiatry; 2016 Feb; 73(2):113-20. PubMed ID: 26719911
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Duration of Untreated Prodromal Psychosis and Cognitive Impairments.
    Zhang T; Cui H; Wei Y; Tang X; Xu L; Hu Y; Tang Y; Liu H; Wang Z; Chen T; Li C; Wang J
    JAMA Netw Open; 2024 Jan; 7(1):e2353426. PubMed ID: 38277145
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical high-risk criteria of psychosis in 8-17-year-old community subjects and inpatients not suspected of developing psychosis.
    Schultze-Lutter F; Walger P; Franscini M; Traber-Walker N; Osman N; Walger H; Schimmelmann BG; Flückiger R; Michel C
    World J Psychiatry; 2022 Mar; 12(3):425-449. PubMed ID: 35433326
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuropsychology of the prodrome to psychosis in the NAPLS consortium: relationship to family history and conversion to psychosis.
    Seidman LJ; Giuliano AJ; Meyer EC; Addington J; Cadenhead KS; Cannon TD; McGlashan TH; Perkins DO; Tsuang MT; Walker EF; Woods SW; Bearden CE; Christensen BK; Hawkins K; Heaton R; Keefe RS; Heinssen R; Cornblatt BA;
    Arch Gen Psychiatry; 2010 Jun; 67(6):578-88. PubMed ID: 20530007
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stressor-Cortisol Concordance Among Individuals at Clinical High-Risk for Psychosis: Novel Findings from the NAPLS Cohort.
    Cullen AE; Addington J; Bearden CE; Stone WS; Seidman LJ; Cadenhead KS; Cannon TD; Cornblatt BA; Mathalon DH; McGlashan TH; Perkins DO; Tsuang MT; Woods SW; Walker EF
    Psychoneuroendocrinology; 2020 May; 115():104649. PubMed ID: 32197198
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disorganized Gyrification Network Properties During the Transition to Psychosis.
    Das T; Borgwardt S; Hauke DJ; Harrisberger F; Lang UE; Riecher-Rössler A; Palaniyappan L; Schmidt A
    JAMA Psychiatry; 2018 Jun; 75(6):613-622. PubMed ID: 29710118
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Brain Age Gap in Early Illness Schizophrenia and the Clinical High-Risk Syndrome: Associations With Experiential Negative Symptoms and Conversion to Psychosis.
    Hua JPY; Abram SV; Loewy RL; Stuart B; Fryer SL; Vinogradov S; Mathalon DH
    Schizophr Bull; 2024 May; ():. PubMed ID: 38815987
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Excessive interstitial free-water in cortical gray matter preceding accelerated volume changes in individuals at clinical high risk for psychosis.
    Cho KIK; Zhang F; Penzel N; Seitz-Holland J; Tang Y; Zhang T; Xu L; Li H; Keshavan M; Whitfield-Gabrieli S; Niznikiewicz M; Stone WS; Wang J; Shenton ME; Pasternak O
    Mol Psychiatry; 2024 Jun; ():. PubMed ID: 38830974
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence of discontinuity between psychosis-risk and non-clinical samples in the neuroanatomical correlates of social function.
    Haas SS; Doucet GE; Antoniades M; Modabbernia A; Corcoran CM; Kahn RS; Kambeitz J; Kambeitz-Ilankovic L; Borgwardt S; Brambilla P; Upthegrove R; Wood SJ; Salokangas RKR; Hietala J; Meisenzahl E; Koutsouleris N; Frangou S
    Schizophr Res Cogn; 2022 Sep; 29():100252. PubMed ID: 35391789
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cognitive deficits profiles in the first-episode of schizophrenia, clinical high risk of psychosis, and genetically high-risk of psychosis.
    Dong F; Mao Z; Ding Y; Wang L; Bo Q; Li F; Wang F; Wang C
    Front Psychiatry; 2023; 14():1292141. PubMed ID: 38146278
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multivariate Associations Among Behavioral, Clinical, and Multimodal Imaging Phenotypes in Patients With Psychosis.
    Moser DA; Doucet GE; Lee WH; Rasgon A; Krinsky H; Leibu E; Ing A; Schumann G; Rasgon N; Frangou S
    JAMA Psychiatry; 2018 Apr; 75(4):386-395. PubMed ID: 29516092
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Various neurocognitive deficits and conversion risk in individuals at clinical high risk for psychosis.
    Mourik K; Decrescenzo P; Brucato G; Gill KE; Arndt L; Kimhy D; Keilp JG; Girgis RR
    Early Interv Psychiatry; 2017 Jun; 11(3):250-254. PubMed ID: 26663764
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in the cognitive function of Chinese college students with a clinical high risk of psychosis.
    Luo X; Zhang L; Zhang J; Chen H; Hong H; Luo R; Ma L; Wang C; Jin F; Wang E; Jiang Z
    Psychiatry Res; 2021 Nov; 305():114242. PubMed ID: 34715440
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discriminatory experiences predict neuroanatomical changes and anxiety among healthy individuals and those at clinical high risk for psychosis.
    Collins MA; Chung Y; Addington J; Bearden CE; Cadenhead KS; Cornblatt BA; Mathalon DH; McGlashan TH; Perkins DO; Seidman LJ; Tsuang MT; Walker EF; Woods SW; Cannon TD
    Neuroimage Clin; 2021; 31():102757. PubMed ID: 34273790
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Progressive reduction in cortical thickness as psychosis develops: a multisite longitudinal neuroimaging study of youth at elevated clinical risk.
    Cannon TD; Chung Y; He G; Sun D; Jacobson A; van Erp TG; McEwen S; Addington J; Bearden CE; Cadenhead K; Cornblatt B; Mathalon DH; McGlashan T; Perkins D; Jeffries C; Seidman LJ; Tsuang M; Walker E; Woods SW; Heinssen R;
    Biol Psychiatry; 2015 Jan; 77(2):147-57. PubMed ID: 25034946
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence of Slow Neural Processing, Developmental Differences and Sensitivity to Cannabis Effects in a Sample at Clinical High Risk for Psychosis From the NAPLS Consortium Assessed With the Human Startle Paradigm.
    Cadenhead KS; Duncan E; Addington J; Bearden C; Cannon TD; Cornblatt BA; Mathalon D; McGlashan TH; Perkins DO; Seidman LJ; Tsuang M; Walker EF; Woods SW; Bauchman P; Belger A; Carrión RE; Donkers F; Johannesen J; Light G; Niznikiewicz M; Nunag J; Roach B
    Front Psychiatry; 2020; 11():833. PubMed ID: 33005152
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Accelerated cortical thinning precedes and predicts conversion to psychosis: The NAPLS3 longitudinal study of youth at clinical high-risk.
    Collins MA; Ji JL; Chung Y; Lympus CA; Afriyie-Agyemang Y; Addington JM; Goodyear BG; Bearden CE; Cadenhead KS; Mirzakhanian H; Tsuang MT; Cornblatt BA; Carrión RE; Keshavan M; Stone WS; Mathalon DH; Perkins DO; Walker EF; Woods SW; Powers AR; Anticevic A; Cannon TD
    Mol Psychiatry; 2023 Mar; 28(3):1182-1189. PubMed ID: 36434057
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.